Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 600 of 866 entries
View as:

Study to Assess Adverse Events When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Real World Setting

Phase: N/A Priority: Normal
NCT ID: NCT04799990 Org: User:
Start: 06/23/21 End: 03/10/22 Due: 03/10/23

Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (PICCOLO)

Phase: N/A Priority: Normal
NCT ID: NCT05041257 Org: User:
Start: 08/31/21 End: 12/12/24 Due: 12/12/25

A Study to Assess Adverse Events and Effectiveness of HAC 20L Injections in Adult Participants for the Treatment of Nasolabial Folds

Phase: N/A Priority: Normal
NCT ID: NCT06018987 Org: User:
Start: 09/05/23 End: 02/03/25 Due: 02/03/26

Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06223516 Org: User:
Start: 06/17/24 End: 02/28/27 Due: 02/28/28

Bioavailability of ABT-450 and ABT-267 With Ritonavir

Phase: N/A Priority: Normal
NCT ID: NCT02052362 Org: User:
Start: 01/31/14 End: 02/28/14 Due: 02/28/15

Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02305758 Org: User:
Start: 12/02/14 End: 09/22/17 Due: 09/22/18

Study to Assess Change in Disease Activity and Adverse Events of RINVOQ in Adult Participants With Ankylosing Spondylitis in the Real-World Japan

Phase: N/A Priority: Normal
NCT ID: NCT05609643 Org: User:
Start: 07/06/22 End: 12/31/25 Due: 12/31/26

A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).

Phase: N/A Priority: Normal
NCT ID: NCT02980731 Org: User:
Start: 12/13/16 End: 12/29/21 Due: 12/29/22

SC-004 Alone or With ABBV-181 in Subjects With Epithelial Ovarian, Fallopian Tube, Primary Peritoneal and Endometrial Cancers

Phase: N/A Priority: Normal
NCT ID: NCT03138408 Org: User:
Start: 06/14/17 End: 05/02/19 Due: 05/02/20

A Study to Assess Resistance and Durability of Response to ABT-493 and/or ABT-530

Phase: N/A Priority: Normal
NCT ID: NCT02441283 Org: User:
Start: 06/22/15 End: 10/15/19 Due: 10/15/20

A Prospective, Mono-Country and Multi-center Study to Observe Safety and Effectiveness of Adalimumab in KoREan Intestinal Behcet's Disease(BD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT02687828 Org: User:
Start: 02/18/16 End: 03/30/20 Due: 03/30/21

Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT04807972 Org: User:
Start: 05/28/21 End: 03/25/24 Due: 03/25/25

Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease in Belgium

Phase: N/A Priority: Normal
NCT ID: NCT06581042 Org: User:
Start: 09/27/24 End: 09/30/29 Due: 09/30/30

A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in China

Phase: N/A Priority: Normal
NCT ID: NCT05821855 Org: User:
Start: 12/08/23 End: 07/31/30 Due: 07/31/31

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

Phase: N/A Priority: Normal
NCT ID: NCT06012240 Org: User:
Start: 10/11/23 End: 01/31/28 Due: 01/31/29

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, Participants With Generalized Anxiety Disorder (GAD) and Participants With Bipolar Disorder (BPD)

Phase: N/A Priority: Normal
NCT ID: NCT06024239 Org: User:
Start: 08/31/23 End: 03/04/25 Due: 03/04/26

A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03484520 Org: User:
Start: 07/23/18 End: 12/01/22 Due: 12/01/23

A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in Adult Participants For the Improvement of Skin Quality

Phase: N/A Priority: Normal
NCT ID: NCT06547125 Org: User:
Start: 07/18/24 End: 06/30/26 Due: 06/30/27

A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

Phase: N/A Priority: Normal
NCT ID: NCT06524635 Org: User:
Start: 08/14/24 End: 02/28/27 Due: 02/28/28

A Study to Assess Adverse Events and Effectiveness of HAC 22L Injection for Mid-Face Volume in Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05818709 Org: User:
Start: 06/14/23 End: 01/05/26 Due: 01/05/27

Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04578756 Org: User:
Start: 02/01/21 End: 09/14/25 Due: 09/14/26

Changes in Ultrasonographic Assessment of Inflammation Upon Initiation of Adalimumab Combination Therapy in Chinese Rheumatoid Arthritis (RA) Patients With Inadequate Response to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT02786563 Org: User:
Start: 09/30/18 End: 11/21/18 Due: 11/21/19

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06846320 Org: User:
Start: 04/29/25 End: 11/30/26 Due: 11/30/27

A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment

Phase: N/A Priority: Normal
NCT ID: NCT03374917 Org: User:
Start: 04/18/18 End: 03/04/19 Due: 03/04/20

Long-term Safety and Efficacy Extension Trial of Bimatoprost SR

Phase: N/A Priority: Normal
NCT ID: NCT03891446 Org: User:
Start: 03/27/19 End: 08/07/26 Due: 08/07/27